These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 9648772)

  • 21. MR imaging with i.v. superparamagnetic iron oxide: efficacy in the detection of focal hepatic lesions.
    Winter TC; Freeny PC; Nghiem HV; Mack LA; Patten RM; Thomas CR; Elliott S
    AJR Am J Roentgenol; 1993 Dec; 161(6):1191-8. PubMed ID: 8249724
    [TBL] [Abstract][Full Text] [Related]  

  • 22. RES-specific imaging of the liver and spleen with iron oxide particles designed for blood pool MR-angiography.
    Bremer C; Allkemper T; Baermig J; Reimer P
    J Magn Reson Imaging; 1999 Sep; 10(3):461-7. PubMed ID: 10508309
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of blood-pool contrast media on MR imaging and flow measurements in the presence of pulmonary arterial stents in swine.
    Kuehne T; Saeed M; Moore P; Gleason K; Reddy G; Teitel D; Higgins CB
    Radiology; 2002 May; 223(2):439-45. PubMed ID: 11997550
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiac magnetic resonance angiography using blood-pool contrast agents: comparison of citrate-coated very small superparamagnetic iron oxide particles with gadofosveset trisodium in pigs.
    Schnorr J; Taupitz M; Schellenberger EA; Warmuth C; Fahlenkamp UL; Wagner S; Kaufels N; Wagner M
    Rofo; 2012 Feb; 184(2):105-12. PubMed ID: 22179768
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ring enhancement in ultrasmall superparamagnetic iron oxide MR imaging: a potential new sign for characterization of liver lesions.
    Mergo PJ; Helmberger T; Nicolas AI; Ros PR
    AJR Am J Roentgenol; 1996 Feb; 166(2):379-84. PubMed ID: 8553952
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differentiation of liver hemangiomas from metastases and hepatocellular carcinoma at MR imaging enhanced with blood-pool contrast agent Code-7227.
    Harisinghani MG; Saini S; Weissleder R; Halpern EF; Schima W; Rubin DL; Stillman AE; Sica GT; Small WC; Hahn PF
    Radiology; 1997 Mar; 202(3):687-91. PubMed ID: 9051017
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MR imaging with ultrasmall superparamagnetic iron oxide particles in experimental soft-tissue infections in rats.
    Kaim AH; Wischer T; O'Reilly T; Jundt G; Fröhlich J; von Schulthess GK; Allegrini PR
    Radiology; 2002 Dec; 225(3):808-14. PubMed ID: 12461265
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Off-resonance angiography: a new method to depict vessels--phantom and rabbit studies.
    Korosoglou G; Shah S; Vonken EJ; Gilson WD; Schär M; Tang L; Kraitchman DL; Boston RC; Sosnovik DE; Weiss RG; Weissleder R; Stuber M
    Radiology; 2008 Nov; 249(2):501-9. PubMed ID: 18780823
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety and preliminary findings with the intravascular contrast agent NC100150 injection for MR coronary angiography.
    Taylor AM; Panting JR; Keegan J; Gatehouse PD; Amin D; Jhooti P; Yang GZ; McGill S; Burman ED; Francis JM; Firmin DN; Pennell DJ
    J Magn Reson Imaging; 1999 Feb; 9(2):220-7. PubMed ID: 10077017
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ultrasmall superparamagnetic iron oxide particles (AMI 227) as a blood pool contrast agent for MR angiography: experimental study in rabbits.
    Loubeyre P; Zhao S; Canet E; Abidi H; Benderbous S; Revel D
    J Magn Reson Imaging; 1997; 7(6):958-62. PubMed ID: 9400837
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pulmonary hemorrhage: imaging with a new magnetic resonance blood pool agent in conjunction with breathheld three-dimensional magnetic resonance angiography.
    Weishaupt D; Hilfiker PR; Schmidt M; Debatin JF
    Cardiovasc Intervent Radiol; 1999; 22(4):321-5. PubMed ID: 10415223
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MR imaging of spatial extent of microvascular injury in reperfused ischemically injured rat myocardium: value of blood pool ultrasmall superparamagnetic particles of iron oxide.
    Krombach GA; Wendland MF; Higgins CB; Saeed M
    Radiology; 2002 Nov; 225(2):479-86. PubMed ID: 12409583
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Equilibrium-phase MR angiography of the aortoiliac and renal arteries using a blood pool contrast agent.
    Weishaupt D; Rühm SG; Binkert CA; Schmidt M; Patak MA; Steybe F; McGill S; Debatin JF
    AJR Am J Roentgenol; 2000 Jul; 175(1):189-95. PubMed ID: 10882273
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interstitial MR lymphography with iron oxide particles: results in tumor-free and VX2 tumor-bearing rabbits.
    Taupitz M; Wagner S; Hamm B; Binder A; Pfefferer D
    AJR Am J Roentgenol; 1993 Jul; 161(1):193-200. PubMed ID: 8517301
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characteristics of ultrasmall superparamagnetic iron oxides in patients with brain tumors.
    Taschner CA; Wetzel SG; Tolnay M; Froehlich J; Merlo A; Radue EW
    AJR Am J Roentgenol; 2005 Dec; 185(6):1477-86. PubMed ID: 16304001
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Imaging of iron oxide nanoparticles by MR and light microscopy in patients with malignant brain tumours.
    Neuwelt EA; Várallyay P; Bagó AG; Muldoon LL; Nesbit G; Nixon R
    Neuropathol Appl Neurobiol; 2004 Oct; 30(5):456-71. PubMed ID: 15488022
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Superparamagnetic iron oxide--enhanced versus gadolinium-enhanced MR imaging for differential diagnosis of focal liver lesions.
    Vogl TJ; Hammerstingl R; Schwarz W; Mack MG; Müller PK; Pegios W; Keck H; Eibl-Eibesfeldt A; Hoelzl J; Woessmer B; Bergman C; Felix R
    Radiology; 1996 Mar; 198(3):881-7. PubMed ID: 8628887
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Superparamagnetic iron oxide particles: what value has the T1 effect in the MR diagnosis of focal liver lesions?].
    Urhahn R; Adam G; Busch N; Chen JH; Euringer W; Günther RW
    Rofo; 1996 Oct; 165(4):364-70. PubMed ID: 8963049
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluating size-dependent relaxivity of PEGylated-USPIOs to develop gadolinium-free T1 contrast agents for vascular imaging.
    Khandhar AP; Wilson GJ; Kaul MG; Salamon J; Jung C; Krishnan KM
    J Biomed Mater Res A; 2018 Sep; 106(9):2440-2447. PubMed ID: 29664208
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rapid-clearance iron nanoparticles for inflammation imaging of atherosclerotic plaque: initial experience in animal model.
    Sigovan M; Boussel L; Sulaiman A; Sappey-Marinier D; Alsaid H; Desbleds-Mansard C; Ibarrola D; Gamondès D; Corot C; Lancelot E; Raynaud JS; Vives V; Laclédère C; Violas X; Douek PC; Canet-Soulas E
    Radiology; 2009 Aug; 252(2):401-9. PubMed ID: 19703881
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.